Table 1 The incidence of pulmonary embolism (symptomatic and incidental groups) in different types of cancers
From: The incidence and clinical characteristics of pulmonary embolism in oncologic patients
Total no of cancer patients (540) | Total no. and % of symptomatic PE 17 (3.14%) | Total no. and %of incidental PE 7 (1.3%) | No. and % of PE/total no. of cancer (24) 4.445% | ||
|---|---|---|---|---|---|
χ2 | P | ||||
Ca breast | 315 | 7 (2.23%) | 1 (0.31%) | 2.8 | ≤ 0.05** |
Ca lung | 31 | –- | 1 (3.5%) | 1.4 | 0.56 |
Ca prostate | 42 | 2 (4.7%) | ––– | 1.9 | 0.69 |
Ca colon | 75 | 4 (5.34%) | 1 (1.34%) | 1.47 | 0.48 |
Ca pancreas | 12 | –– | 2 (16.7%) | 3.7 | ≤ 0.05** |
Ca gall bladder | 6 | 1 (16.67%) | 1 (16.67%) | 1.0 | 0.25 |
Ca uterus | 4 | ––- | 1 (25%) | 1.4 | 0.67 |
Ca larnex | 3 | 1 (33.4%) | ––- | 1.8 | 0.78 |
Seminoma and germ cell tumor | 4 | 2 (50%) | ––- | 2.4 | ≤ 0.05** |